BioTuesdays

Tag - BIOC

maxim Group Logo
Markets

Maxim reduces PTs in challenging biotech market

Maxim Group analyst Jason McCarthy, Ph.D., reduced price targets for 13 stocks in his coverage universe, citing macroeconomic winds and a significant decline in stock prices, particularly for small-cap biotech stocks...

May 26, 2022
Biocept Logo
Markets

Brookline starts Biocept at buy; PT $2.06

Brookline Capital Markets initiated coverage of Biocept (NASDAQ:BIOC) with a “buy” rating and price target of $2.06. The stock closed at 44 cents on May 13. Biocept is a molecular oncology diagnostics company that...

May 14, 2020
Biocept Logo
Developments

Biocept launches liquid biopsy lung cancer test

Biocept (NASDAQ:BIOC) launched its multi-gene liquid biopsy panel for the detection of biomarkers associated with lung cancer. The difficulty of obtaining lung tissue samples from patients has previously limited access...

May 21, 2019